- Home
- CVKD vs AQMS Comparison
CVKD vs AQMS Comparison
Compare CVKD & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- AQMS
- Stock Information
- Founded
- CVKD 2022
- AQMS 2014
- Country
- CVKD United States
- AQMS United States
- Employees
- CVKD N/A
- AQMS N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- AQMS Metal Fabrications
- Sector
- CVKD Health Care
- AQMS Industrials
- Exchange
- CVKD Nasdaq
- AQMS Nasdaq
- Market Cap
- CVKD 27.0M
- AQMS 24.2M
- IPO Year
- CVKD 2023
- AQMS 2015
- Fundamental
- Price
- CVKD $11.25
- AQMS $6.43
- Analyst Decision
- CVKD Strong Buy
- AQMS Buy
- Analyst Count
- CVKD 1
- AQMS 1
- Target Price
- CVKD $32.00
- AQMS $12.00
- AVG Volume (30 Days)
- CVKD 21.9K
- AQMS 921.8K
- Earning Date
- CVKD 11-10-2025
- AQMS 11-12-2025
- Dividend Yield
- CVKD N/A
- AQMS N/A
- EPS Growth
- CVKD N/A
- AQMS N/A
- EPS
- CVKD N/A
- AQMS N/A
- Revenue
- CVKD N/A
- AQMS N/A
- Revenue This Year
- CVKD N/A
- AQMS N/A
- Revenue Next Year
- CVKD N/A
- AQMS $550.00
- P/E Ratio
- CVKD N/A
- AQMS N/A
- Revenue Growth
- CVKD N/A
- AQMS N/A
- 52 Week Low
- CVKD $8.74
- AQMS $3.37
- 52 Week High
- CVKD $22.90
- AQMS $39.40
- Technical
- Relative Strength Index (RSI)
- CVKD 39.39
- AQMS 45.28
- Support Level
- CVKD $11.51
- AQMS $6.44
- Resistance Level
- CVKD $13.01
- AQMS $8.10
- Average True Range (ATR)
- CVKD 0.82
- AQMS 1.20
- MACD
- CVKD -0.14
- AQMS -0.30
- Stochastic Oscillator
- CVKD 21.29
- AQMS 0.58
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.